With our advanced plate of Tumor Profiling to Guide Targeted Cancer Therapy, Creative Biolabs has developed an unparalleled platform for tumor profiling in colorectal cancer. To fulfill every need of our consumers, our professional scientists are ready to start working on your projects.

Introduction of Tumor Profiling in Colorectal Cancer

Colorectal cancer (CRC) is the most diagnosed cancer and the third most common worldwide cancer. It is extremely high heterogeneity with multi-genetic and episcopic alterations. The gene mutation, DNA mismatch, and protein changes result in uncontrolled cell proliferation without regular immune response, and progression to CRC or even a malignant cancer. In the era of precision medicine, advances in tumor profiling technology have boosted the demystification process of CRC heterogeneity. A comprehensive tumor profiling could improve the therapeutic effectiveness and avoid useless effort failure on drug resistance in the CRC diagnosis and treatment.

Fig.1 Features of the CRC tumor profiling platform. (Zhao, et al., 2022)

CRC Tumor Profiling at Creative Biolabs

• Technologies for CRC tumor profiling

Recent advances in Technologies for Tumor Profiling have provided us insight into the heterogeneity of CRC cancer. The molecular and immune profiling technologies we provide for CRC include but are not limited to:

• List of some well-studied CRC biomarkers

• Biological samples for CRC tumor profiling

The biological samples could be primary tumor biopsies, cell lines, liquid biopsies, stool, and so on.

Fig.2 Different kinds of biological samples for CRC study. (Lindhorst & Hummon, 2020)

• Applications of CRC tumor profiling

Fig.2 Different kinds of biological samples for CRC study. (Lindhorst & Hummon, 2020)

Features of CRC Tumor Profiling at Creative Biolabs

Creative Biolabs provides tumor profiling of premium quality with effective and timely delivery for our worldwide clients. Our repertoire of expertise offers a list of techniques for biomarker identification, diagnosis, prognosis, and personalized therapy. For more details, please don't hesitate to contact us directly.

References

1. Zhao, Q.; et al. Comprehensive profiling of 1015 patients' exomes reveals genomic-clinical associations in colorectal cancer. Nature communications. 2022, 13(1): 2342.
2. Lindhorst, P.H.; Hummon, A.B. Proteomics of colorectal cancer: Tumors, organoids, and cell cultures-A minireview. Frontiers in molecular biosciences. 2020, 7: 604492.

For Research Use Only | Not For Clinical Use